Recombinant human thrombopoietin in combination with cyclosporin A as a novel therapy in corticosteroid-resistant primary immune thrombocytopenia

Background The management of patients with refractory immune thrombocytopenia （ITP） is challenging, as there is no standard treatment option. The aim of this study was to investigate the efficacy of recombinant human thrombopoietin （rhTPO） in combination with cyclosporin A （CsA） for the management o...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Chinese medical journal 2013-11, Vol.126 (21), p.4145-4148
Hauptverfasser:	Cui, Zhong-Guang, Liu, Xin-Guang, Qin, Ping, Hou, Ming, Wu, Shao-Ling, Peng, Jun, Zhao, Hong-Guo, Wang, Hong-Yi, Zhao, Chun-Ting
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adrenal Cortex Hormones - therapeutic use Adult Aged Cyclosporine - administration & dosage Cyclosporine - therapeutic use Drug Resistance Female Humans Male Middle Aged Recombinant Proteins - therapeutic use Thrombocytopenia - drug therapy Thrombopoietin - adverse effects Thrombopoietin - therapeutic use Treatment Outcome Young Adult 人血小板生成素免疫性治疗方案环孢素A 皮质素性血小板减少重组
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Background The management of patients with refractory immune thrombocytopenia （ITP） is challenging, as there is no standard treatment option. The aim of this study was to investigate the efficacy of recombinant human thrombopoietin （rhTPO） in combination with cyclosporin A （CsA） for the management of patients with corticosteroid-resistant primary ITP.
ISSN:	0366-6999 2542-5641
DOI:	10.3760/cma.j.issn.0366-6999.20131116